Mizuho set a $30.00 target price on Acadia Healthcare (NASDAQ:ACHC) in a research note published on Friday, May 31st, TipRanks reports. The brokerage currently has a hold rating on the stock.
Several other brokerages also recently commented on ACHC. BMO Capital Markets increased their price target on Acadia Healthcare from $33.00 to $36.00 and gave the company a market perform rating in a report on Wednesday, May 1st. BidaskClub upgraded shares of Acadia Healthcare from a hold rating to a buy rating in a research note on Wednesday, May 22nd. Deutsche Bank set a $32.00 price objective on shares of Acadia Healthcare and gave the stock a hold rating in a research note on Thursday, May 2nd. ValuEngine upgraded shares of Acadia Healthcare from a strong sell rating to a sell rating in a research note on Wednesday, April 24th. Finally, Citigroup decreased their price target on shares of Acadia Healthcare from $43.00 to $38.00 and set a buy rating on the stock in a research note on Monday, March 4th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of Hold and an average price target of $36.80.
ACHC traded down $0.14 during midday trading on Friday, hitting $34.31. 601,501 shares of the company’s stock traded hands, compared to its average volume of 958,993. Acadia Healthcare has a one year low of $24.27 and a one year high of $45.35. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 1.55. The company’s fifty day moving average price is $33.24. The stock has a market capitalization of $3.07 billion, a P/E ratio of 15.32, a PEG ratio of 1.85 and a beta of 0.64.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.35 by $0.04. Acadia Healthcare had a positive return on equity of 7.33% and a negative net margin of 6.50%. The company had revenue of $760.60 million for the quarter, compared to the consensus estimate of $762.02 million. During the same quarter last year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 2.5% compared to the same quarter last year. On average, equities analysts forecast that Acadia Healthcare will post 2.21 earnings per share for the current fiscal year.
Several institutional investors have recently added to or reduced their stakes in the stock. Nordea Investment Management AB lifted its stake in Acadia Healthcare by 1.3% in the 1st quarter. Nordea Investment Management AB now owns 140,136 shares of the company’s stock valued at $4,107,000 after acquiring an additional 1,758 shares in the last quarter. Clearbridge Investments LLC bought a new stake in Acadia Healthcare in the 1st quarter valued at approximately $12,709,000. Marshall Wace North America L.P. bought a new stake in Acadia Healthcare in the 1st quarter valued at approximately $1,342,000. Maso Capital Partners Ltd lifted its stake in Acadia Healthcare by 5.8% in the 1st quarter. Maso Capital Partners Ltd now owns 108,200 shares of the company’s stock valued at $3,171,000 after acquiring an additional 5,900 shares in the last quarter. Finally, TCW Group Inc. raised its stake in shares of Acadia Healthcare by 17.9% during the 1st quarter. TCW Group Inc. now owns 65,319 shares of the company’s stock worth $1,914,000 after purchasing an additional 9,917 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Recommended Story: Inflation
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.